/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

HALEON PLC SPON ADS

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$9.51 -0.0165(-1.65%) HLN at 04 Dec 2025 04:34 PM Drug Manufacturers - Specialty & Generic
Lowest Today 9.51
Highest Today 9.77
Today’s Open 9.7
Prev. Close 9.67
52 Week High 11.35
52 Week Low 8.70
Day’s Range: Low 9.51 High 9.77
52-Week Range: Low 8.70 High 11.35
1 day return -
1 Week return -2.65
1 month return +1.92
3 month return -3.35
6 month return -12.98
1 year return -1.85
3 year return +33.07
5 year return -
10 year return -

Institutional Holdings

Dodge & Cox 3.47

Dodge & Cox Stock I 2.51

FMR Inc 2.50

ClearBridge Advisors, LLC 0.70

Harding Loevner L.P. 0.50

Morgan Stanley - Brokerage Accounts 0.40

Wellington Management Company LLP 0.37

Fidelity Series Large Cap Stock 0.31

Bank of America Corp 0.28

Dodge & Cox Balanced Composite 0.27

Dodge & Cox Balanced I 0.27

Strategic Advisers Fidelity US TtlStk 0.25

OZ Management LLC 0.22

Fidelity Growth & Income 0.20

JPMorgan Chase & Co 0.20

Aristotle Capital Management LLC 0.18

Douglas Lane & Associates, LLC 0.18

Altshuler Shaham Ltd 0.18

Envestnet Asset Management Inc 0.18

Renaissance Technologies Corp 0.17

Goldman Sachs Group Inc 0.17

VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.16

Rockefeller Capital Management L.P. 0.15

BlackRock Inc 0.14

UBS Group AG 0.14

Nuveen, LLC 0.13

Hartford Dividend and Growth Y 0.13

Fidelity Large Cap Stock 0.08

ClearBridge Large Cap Value 0.08

ClearBridge Large Cap Value I 0.08

Fidelity Advisor Capital Development O 0.08

Dodge & Cox Worldwide US Stock A EUR 0.06

CREF Stock R3 0.05

Fidelity Mega Cap Stock 0.05

VanEck Pharmaceutical ETF 0.05

Desjardins American Equity Value A 0.05

Fidelity VIP Growth & Income Initial 0.04

Touchstone Non-US Equity A 0.04

AST Large-Cap Value Portfolio 0.04

Pacific Select Large-Cap Value I 0.03

Market Status

Strong Buy: 2

Buy: 2

Hold: 0

Sell: 1

Strong Sell: 0

Fundamentals

Market Cap 43060.13 M

PB Ratio 2.0679

PE Ratio 21.9773

Enterprise Value 54025.35 M

Total Assets 34315.00 M

Volume 12247626

Company Financials

Annual Revenue FY23:11302000000 11302.0M, FY22:10858000000 10858.0M, FY21:9545000000 9545.0M, FY20:9892000000 9892.0M, FY19:8480000000 8480.0M

Annual Profit FY23:6962000000 6962.0M, FY22:6577000000 6577.0M, FY21:5950000000 5950.0M, FY20:5910000000 5910.0M, FY19:4802000000 4802.0M

Annual Net worth FY23:1049000000 1049.0M, FY22:1060000000 1060.0M, FY21:1390000000 1390.0M, FY20:1145000000 1145.0M, FY19:655000000 655.0M

Quarterly Revenue Q2/2025:2740000000 2740.0M, Q1/2025:2740000000 2740.0M, Q2/2024:2775000000 2775.0M, Q1/2024:2919000000 2919.0M, Q4/2023:2766000000 2766.0M

Quarterly Profit Q2/2025:1767500000 1767.5M, Q1/2025:1767500000 1767.5M, Q2/2024:1796000000 1796.0M, Q1/2024:1838000000 1838.0M, Q4/2023:1481000000 1481.0M

Quarterly Net worth Q2/2025:403000000 403.0M, Q1/2025:403000000 403.0M, Q2/2024:303000000 303.0M, Q1/2024:423000000 423.0M, Q4/2023:-3000000 -3.0M

Fund house & investment objective

Company Information Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Organisation Drug Manufacturers - Specialty & Generic

Employees 24561

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Brian James McNamara

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow